Navigation Links
Medical Marijuana, Inc. Reports Record First Quarter 2013 Revenue and Income
Date:4/11/2013

, tractability and our ability to quickly launch products. The company believes HempMeds has the ability to create groundswells within the cannabis and hemp industry online product sales and marketing community.
  • The company has greatly expanded its portfolio of products and has put these products into manufacturing over the first quarter of 2013. These products are to be launched this month. Products include CBD-Vape oil and vaporizers, reformulated and branded CBD product lines, Bulk Wholesales raw ingredients, CanChew Over the counter CBD gum, Flavored Vape-CBD product lines and many more.
  • The Company continued to explore several potential acquisition and investment opportunities in established cannabis and hemp related businesses. Expecting closings in May, 2013.
  • Update on Audit-

    In addition, since the close of the first quarter, Medical Marijuana, Inc. continued to retain its auditing firm to perform the audit of its financial records for the quarter ending March 31, 2013 and all the way back for a twenty four month audit history. The Company completed all of the pre-audit work during Q4 and submitted its first audited financials for the quarter ending December 31, 2012. We expect the twenty four months of audit history to be completed no sooner than the end of Q2 of 2013.

    Update on DTC-

    The company had previously submitted all requested documentation from the Depository Trust Corporation (DTC) for the requested "chill" removal, since then the DTC has requested some additional documentation which will be submitted to them in April. Our corporate counsel has addressed in writing and written a legal opinion letter for the DTC to address their questions.

    Update on up listing and fully reporting status with SEC.

    The company has positioned itself to become fully reporting with the Securities and Exchange Commission (SEC) once the twenty four month audit history is completed by the PCAOB auditing f
    '/>"/>

    SOURCE Medical Marijuana, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Lung Cancer Alliance Congratulates 75 Medical Centers For Moving Swiftly And Responsibly On Lung Cancer Screening
    2. Medical Device Developers - Network at BIOMEDevice Boston Next Week
    3. Winner Medicals Special Committee Appoints Independent Financial Advisor and Retains Legal Counsel
    4. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
    5. CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58 Million
    6. ulrich medical USA™ Releases New Expandable Spinal Implant for US Market
    7. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
    8. Essential Medical Dismisses Patent Case against Masimo and Cercacor
    9. Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier®
    10. Aethlon Medical Note: Marc Robins Joins the Aethlon Team
    11. Enox Biopharma, Inc. To Present Today At IN3 Medical Device 360 Conference In London
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/30/2014)... Sept. 30, 2014 CytRx Corporation (NASDAQ: ... development company specializing in oncology, today announced the ... evaluating aldoxorubicin compared to topotecan in subjects with ... relapsed or were refractory to prior chemotherapy. Aldoxorubicin ... agent, doxorubicin. CytRx has received Orphan Drug Designation ...
    (Date:9/29/2014)... Fla. and DUBLIN , ... ("we" or the "Company"), a biotechnology company pioneering the ... marketing of innovative therapies for cancer, HIV/AIDS, opportunistic infections ... to its shareholders from CEO Noreen Griffin The letter ... Inc. (the "Company" or "TNIB") received a number of ...
    (Date:9/29/2014)... , Sept. 29, 2014  Moberg ( www.moberg.com ... CNS Monitor, a medical device used for advanced ... Mark certifies that a product has met European ... Europe . The CNS Monitor ... (EEG, or brain waves) to support neurological patient ...
    Breaking Medicine Technology:CytRx Initiates Global Phase 2b Clinical Trial of Aldoxorubicin for the Treatment of Relapsed/Refractory Small Cell Lung Cancer 2CytRx Initiates Global Phase 2b Clinical Trial of Aldoxorubicin for the Treatment of Relapsed/Refractory Small Cell Lung Cancer 3CytRx Initiates Global Phase 2b Clinical Trial of Aldoxorubicin for the Treatment of Relapsed/Refractory Small Cell Lung Cancer 4CytRx Initiates Global Phase 2b Clinical Trial of Aldoxorubicin for the Treatment of Relapsed/Refractory Small Cell Lung Cancer 5TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Cytocom Dividend 2TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Cytocom Dividend 3TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Cytocom Dividend 4TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Cytocom Dividend 5TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Cytocom Dividend 6TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Cytocom Dividend 7TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Cytocom Dividend 8Moberg CNS Monitor Receives European CE Mark Approval for Advanced Neurological Monitoring 2
    ... Annual Meeting- , , ... of a randomized phase III study presented at the ... The study in adult patients with hematological malignancies at ... demonstrated that Elitek(R) (rasburicase) significantly reduced plasma uric acid ...
    ... Analgesic Significantly Reduces Postop Pain, Opioid Use, and ... Standard Pain Medication , ... A Phase II dose escalation study of a ... who underwent total knee arthroplasty, or TKA, showed ...
    Cached Medicine Technology:Phase III Trial Results Show Elitek(R) (rasburicase) Significantly Reduced Plasma Uric Acid Levels versus Allopurinol in Adults with Hematologic Cancers at Risk for Tumor Lysis Syndrome 2Phase III Trial Results Show Elitek(R) (rasburicase) Significantly Reduced Plasma Uric Acid Levels versus Allopurinol in Adults with Hematologic Cancers at Risk for Tumor Lysis Syndrome 3Phase III Trial Results Show Elitek(R) (rasburicase) Significantly Reduced Plasma Uric Acid Levels versus Allopurinol in Adults with Hematologic Cancers at Risk for Tumor Lysis Syndrome 4Phase III Trial Results Show Elitek(R) (rasburicase) Significantly Reduced Plasma Uric Acid Levels versus Allopurinol in Adults with Hematologic Cancers at Risk for Tumor Lysis Syndrome 5Positive Phase II Study of Pacira's EXPAREL(TM) (DepoBupivacaine) in Total Knee Arthroplasty Presented at International College of Surgeons World Congress 2Positive Phase II Study of Pacira's EXPAREL(TM) (DepoBupivacaine) in Total Knee Arthroplasty Presented at International College of Surgeons World Congress 3Positive Phase II Study of Pacira's EXPAREL(TM) (DepoBupivacaine) in Total Knee Arthroplasty Presented at International College of Surgeons World Congress 4
    (Date:9/30/2014)... Amy Norton HealthDay ... -- Long-acting contraceptive devices should be the first choice ... the American Academy of Pediatrics state. Although most ... two other forms of contraception -- intrauterine devices (IUDs) ... to the academy. And they should be the ...
    (Date:9/30/2014)... VA (PRWEB) September 30, 2014 Visit ... of Chestnut Hill and you will find a loving ... together, Amyotrophic Lateral Sclerosis. , Steve was ... or Lou Gehrig’s Disease – just before the couple’s ... primary caregiver. , A new video, “Care, Support ...
    (Date:9/30/2014)... Franklin, TN (PRWEB) September 30, 2014 ... millions of people throughout the United States and ... of Parkinson’s Disease are diagnosed each year, adding ... diagnosed with the disease. Approximately 400,000 people in ... 2.3 million worldwide. Add to these statistics the ...
    (Date:9/30/2014)... 2014 Pivotal 5, LLC, a proven ... Life Time – The Healthy Way of Life CompanySM ... KettleWorX Group Training . KettleWorX Group Training is a ... offers consumers of all fitness levels a means to ... manner. The rollout to Life Time Athletic destinations will ...
    (Date:9/30/2014)... HealthDay Reporter TUESDAY, Sept. 30, 2014 (HealthDay ... the return of a common type of irregular heartbeat known ... percent of those taking fish oil for its omega-3 fatty ... of 16 months, compared to 63.2 percent of those ... the twin ills of inflammation or oxidative stress, which may ...
    Breaking Medicine News(10 mins):Health News:Pediatricians Endorse IUDs, Implants for Teen Birth Control 2Health News:Pediatricians Endorse IUDs, Implants for Teen Birth Control 3Health News:Hospice Provides Care and Support to Patients and Family Caregivers with ALS 2Health News:North American Seminars Introduces a New OT PT CME Course, Evidence Based Rehab Techniques for Parkinsons, Multiple Sclerosis and Peripheral Neuropathy 2Health News:North American Seminars Introduces a New OT PT CME Course, Evidence Based Rehab Techniques for Parkinsons, Multiple Sclerosis and Peripheral Neuropathy 3Health News:Pivotal 5 Announces Life Time Fitness As National Destination For KettleWorX Kettlebell Training 2Health News:Pivotal 5 Announces Life Time Fitness As National Destination For KettleWorX Kettlebell Training 3Health News:Fish Oil Supplements Have Little Effect on Irregular Heartbeat: Study 2Health News:Fish Oil Supplements Have Little Effect on Irregular Heartbeat: Study 3
    ... School of Medicine and colleagues discovered that the Notch ... types, and is also implicated in some cancers, is ... The findings appear this week in Cell Stem Cell, ... bone marrow stem cells. , Notch is one of ...
    ... the Head and Neck, NEW YORK, April 10 ... plastic and cosmetic surgery for the ethnic,patient, will speak ... day,Continuing Medical Education (CME) Accredited seminar entitled "Patient,Safety in ... 12 at the,University Club of New York., "Facial ...
    ... Support Event, ALEXANDRIA, Va., April 10 ... (NHDD), will be the largest,effort ever undertaken to ... "With healthcare, ,your decisions matter;, however, others ... Nathan A. Kottkamp, Chair, National,Healthcare Decisions Day. "All ...
    ... in wine that protect against dementia. This is shown in ... Sweden. , The findings are based on 1,458 women who ... 1968. When they were examined by physicians they were asked ... by selecting from seven categories on a scale from never ...
    ... - 7,000 deaths a year ... pharmacy error risk, - Half of consumers choose their pharmacies for ... ... One-third of America,s 225,million prescription-takers now report experiencing a prescription ...
    ... their children to a podiatrist,for foot ailments, BETHESDA, ... bring thousands of adults to doctors, offices every,day. But ... Medical Association (APMA) during April,s Foot Health Awareness,Month, many ... it comes to their children,s feet. In fact, only ...
    Cached Medicine News:Health News:Developing cancer treatments directed at critical developmental pathway 2Health News:Dr. Edmund Kwan to Speak on Facial Contouring Among Asian Patients at Cosmetic Surgery Seminar 2Health News:National Healthcare Decisions Day in All 50 States, DC, Puerto Rico, and Internationally 2Health News:Wine may protect against dementia 2Health News:Prescription For Disaster: One-Third of Consumers Experience Prescription Errors, New Survey Finds 2Health News:Prescription For Disaster: One-Third of Consumers Experience Prescription Errors, New Survey Finds 3Health News:Pediatric Survey Reveals Many Parents Neglect Their Children's Feet 2
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    Medicine Products: